Fahmy, L. M., Schreidah, C. M., McDonnell, D. E., Carvajal, R. D., Magro, C. M., & Geskin, L. J. (2024). Cutaneous type IV hypersensitivity reaction following tebentafusp treatment for uveal melanoma. Dermatology Online Journal, 29(6). https://doi.org/10.5070/d329662993

Kang, J., Park, J., Jo, H., Lee, H., Lee, K., Kim, S., Kang, J., Lee, J. H., Papadopoulos, N. G., Lee, S., Shin, J.-Y., Rahmati, M., Cho, S. H., Cho, J. K., Lee, S., Pizzol, D., Yeo, S. G., Lee, H., Jin, S.-P., & Yon, D. K. (2024). Global Burden of Vaccine-Associated Chronic Urticaria, 2010–2023: From the Global Pharmacovigilance Database. Allergy, Asthma & Immunology Research, 16(6), 613. https://doi.org/10.4168/aair.2024.16.6.613

Tashi, T., Hermine, O., Castells, M., Guilarte, M., Sabato, V., Maurer, M., Panse, J., Alvarez-Twose, I., Cabral, R., Bird, R., Barete, S., Bouillet, L., Hermans, M., Van Daele, P., González-De-Olano, D., Griffiths, E. A., Jurcic, J., Dybedal, I., Damaj, G. L., … Livideanu, C. B. (2023). Elenestinib, an Investigational, Next Generation KIT D816V Inhibitor, Reduces Mast Cell Burden, Improves Symptoms, and Has a Favorable Safety Profile in Patients with Indolent Systemic Mastocytosis: Analysis of the Harbor Trial. Blood, 142(Supplement 1), 76–76. https://doi.org/10.1182/blood-2023-188904

Lapolla, B., Gordon, E., Adeuyan, O., Schreidah, C., Fahmy, L., Magro, C., & Geskin, L. (2023). 245 A rare case of erythrodermic sarcoidosis with systemic involvement after COVID-19 vaccination. Journal of Investigative Dermatology, 143(11), S373. https://doi.org/10.1016/j.jid.2023.09.253

Rashidi, A., Shah, C., & Sekulic, M. (2022). The Role of Kidney Biopsy in Immune Checkpoint Inhibitor-Associated AKI. Kidney360, 3(3), 530–533. https://doi.org/10.34067/kid.0000232022